Related Experiment Video
Updated: Jun 20, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Crosstalk in Met receptor oncogenesis
Andrea Z Lai1, Jasmine V Abella, Morag Park
1Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
Abstract:
The Met receptor tyrosine kinase (RTK) regulates several distinct biological processes, including cell scatter, cell invasion, cell survival and epithelial remodeling. MET is genetically altered through several mechanisms in multiple human cancers; these events are causally related to cancer initiation and progression, identifying Met as a potential therapeutic target. Recent evidence highlights additional roles for Met in cancer through crosstalk with other receptors and cell surface proteins. In this review, we discuss recent progress in our understanding of mechanisms of interaction between Met, the epidermal growth factor receptor family and other cell surface protein families, and how these contribute to signal crosstalk, oncogenesis and drug resistance.
Insights
The Met receptor tyrosine kinase (RTK) is crucial in cancer development and progression. Understanding its interactions with other cell surface proteins offers new therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Met receptor tyrosine kinase (RTK) regulates key cellular processes like invasion and survival.
- Genetic alterations in MET are implicated in human cancer initiation and progression, making it a therapeutic target.
Purpose of the Study:
- To review recent advancements in understanding Met interactions.
- To explore how Met crosstalk with other cell surface proteins contributes to oncogenesis and drug resistance.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of mechanisms underlying Met interactions with receptor families.
- Synthesis of data on signal crosstalk and its implications.
Main Results:
- Met plays multifaceted roles in cancer beyond its direct signaling.
- Crosstalk between Met and receptors like EGFR influences cancer pathways.
- These interactions are critical for oncogenesis and the development of drug resistance.
Conclusions:
- Met's complex interactions are central to cancer biology.
- Targeting Met and its associated pathways presents promising therapeutic avenues.
- Further research into Met crosstalk is essential for overcoming cancer drug resistance.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Receptor Tyrosine Kinases
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

